The estimated Net Worth of Glen Donovan is at least $1.01 millió dollars as of 3 March 2021. Mr. Donovan owns over 16,347 units of PPD Inc stock worth over $914,726 and over the last 5 years he sold PPD stock worth over $98,475. In addition, he makes $0 as Chief Accounting Officer at PPD Inc.
Glen has made over 3 trades of the PPD Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 16,347 units of PPD stock worth $173,115 on 3 March 2021.
The largest trade he's ever made was exercising 16,347 units of PPD Inc stock on 3 March 2021 worth over $173,115. On average, Glen trades about 2,811 units every 80 days since 2019. As of 3 March 2021 he still owns at least 19,347 units of PPD Inc stock.
You can see the complete history of Mr. Donovan stock trades at the bottom of the page.
Glen Donovan serves as Chief Accounting Officer of the Company. Prior to joining the Company, Mr. Donovan served in various roles at Deloitte & Touche, a multinational professional services network, from November 1996 to May 2015, including as audit and assurance partner from September 2011 to May 2015.
Glen Donovan is 46, he's been the Chief Accounting Officer of PPD Inc since 2015. There are 13 older and 5 younger executives at PPD Inc. The oldest executive at PPD Inc is Jeffrey Kindler, 64, who is the Independent Director.
Glen's mailing address filed with the SEC is C/O PPD, INC., 929 NORTH FRONT STREET, WILMINGTON, NC, 28401.
Over the last 21 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt... és Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
PPD Inc executives and other stock owners filed with the SEC include: